ITC Starts Clinical Trials of its Covid-19 Nasal Spray

ITC confirmed that the company is developing a covid-19 nasal spray. The spray is in clinical trials for now. The nasal spray is being developed at the ITC Life Sciences and Technology Centre in Bengaluru. According to the sources, the company is planning to launch it under the brand name, Savlon. The company has not disclosed any details about where the clinical trials and the production will be held and the brand name under which it will be launched in the market.

ITC Life Sciences and Technology Center has been the center of developing science-led products for the company. The R&D teams of the company have been involved in developing a wide range of innovative health products that were launched in the market under the brand name, Savlon during the pandemic.